亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

湖北廠家專業生產阿戈美拉汀*CAS: 138112-76-

 
 
單價 20000.00 / 公斤對比
銷量 暫無
發貨 湖北隨州市付款后24小時內
庫存 1000公斤起訂1公斤
品牌 佳科
型號 138112-76-2
規格 1公斤或5公斤/鋁聽
過期 長期有效
更新 2020-12-22 09:17
 

隨州佳科醫藥化工有限公司銷售二部

企業會員第14年
資料未認證
保證金未繳納
詳細說明


阿戈美拉汀
CAS號: 138112-76-2
中文同義詞: 阿戈美拉汀;N-[2-(7-甲氧基萘-1-基)乙基]乙酰胺
英文名字:Agomelatine
英文別名:n-(2-(7-methoxynaphth-1-yl)ethyl)acetamide
英文同義詞: n-(2-(7-methoxy-1-naphthalenyl)ethyl)-acetamid;n-(2-(7-methoxy-1-naphthalenyl)ethyl)acetamide;n-(2-(7-methoxynaphth-1-yl)ethyl)acetamide;S20098,N-[2-(7-Methoxynaphth-1-yl)ethyl]acetamide;S 20098;AGOMELATIN;Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)
分子式: C15H17NO2
分子量: 243.30098
熔點 107-110°C
標準:企業標準
含量:≥99%(HPLC)
性狀:白色或類白色結晶性粉末
用途:抗抑郁原料藥
包裝:1公斤或5公斤/鋁聽

分子式: C15H17NO2
分子量: 243.30098
熔點 107-110°C
標準:企業標準
含量:≥99%(HPLC)

舉報收藏 0評論 0
更多>本企業其它產品
湖北廠家專業生產三氟甲磺酸*CAS:1493-13-6*含量 湖北廠家專業生產芬布芬*CAS:36330-85-5* 含量 湖北廠家專業生產甘草次酸*CAS:1449-05-4*99% 湖北廠家專業生產莫匹羅星*CAS:12650-69-0*含量 卡倍他濱中間體/CAS162204-20-8/廠家生產 培美曲塞二鈉@CAS150399-23-8@谷氨酸二鈉供應商 半合成脂肪酸甘油酯/混合脂肪酸甘油酯
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |